Immune Thrombocytopenia

People with primary immune thrombocytopenia (ITP) are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least ≥18 years of age
• Are diagnosed with primary IPT, with insufficient response or relapsed after first line corticosteroid treatment
• Have platelet count < 30 G/L You may not participate in this study if you: • Have received second-line ITP treatments • Have key lab abnormalities and patients with Evans syndrome or any other cytopenia • Have a history of clinically significant hematological disorders • Have a current or history of life- threatening bleeding • Are HIV, Hepatitis C Virus, or Hepatitis B surface Antigen/ Hepatitis B core antibody positive • Have active or uncontrolled infection requiring systemic treatment during screening • Are pregnant or breast-feeding women Contact Information Noelle Townsend, Study Coordinator Phone: 718-920-4321 Email: NOELLE.TOWNSEND@EINSTEINMED.EDU 23-02-121